Real-world drug survival of tildrakizumab for plaque psoriasis: a 3-year international multicentre retrospective study
- PMID: 40726424
- DOI: 10.1093/ced/llaf342
Real-world drug survival of tildrakizumab for plaque psoriasis: a 3-year international multicentre retrospective study
Conflict of interest statement
Conflicts of interest: The full list of author conflicts of interest can be found in Appendix S2 (see Supporting Information).
LinkOut - more resources
Full Text Sources
